Ab Studio Inc. news

IntoCell, a South Korean biotech developing novel antibody drug conjugate (ADC) platform technologies, today announced the signing of a research collaboration with Ab Studio, a US biotech focused on the discovery of novel antibodies.

The collaboration will include construction of a panel of ADCs by integrating IntoCell`s proprietary payloads and Ortho-Hydroxy Protected Aryl Sulfate (OHPAS) linker technology and Ab Studio`s novel internalising monoclonal antibody. The selected ADCs wil